Iradimed (IRMD) Enterprise Value (2014 - 2026)

Iradimed (IRMD) has reported Enterprise Value for 13 consecutive years, with $1.2 billion the latest figure, recorded in Q2 2026.

• On a quarterly basis, Enterprise Value rose 64.35% year-over-year to $1.2 billion in Q2 2026; TTM through Jun 2026 was $1.2 billion, a 64.35% increase from a year earlier, with the FY2025 full-year figure at $1.2 billion, up 84.33% from the prior year.
• Enterprise Value was $1.2 billion for Q2 2026 at Iradimed, down from $1.2 billion in the prior quarter.
• Over five years, Enterprise Value peaked at $1.2 billion in Q4 2025 and troughed at $298.2 million in Q4 2022.
• A 5-year average of $640.8 million and a median of $553.5 million in 2023 frame the typical range for Enterprise Value.
• The widest YoY moves for Enterprise Value: up 93.61% in 2022, down 42.33% in 2022.
• Over 5 years, Enterprise Value stood at $298.2 million in 2022, then jumped by 84.83% to $551.2 million in 2023, then rose by 17.34% to $646.8 million in 2024, then surged by 84.33% to $1.2 billion in 2025, then decreased by 2.47% to $1.2 billion in 2026.
• The last three Enterprise Value figures came in at $1.2 billion (Q2 2026), $1.2 billion (Q1 2026), and $1.2 billion (Q4 2025), per Business Quant data.